Video Experimental Relacionado

Updated: Sep 10, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

Transbordador de Carnitina y Ferroptosis en el Cáncer

Ye-Ah Kim^1,2, Yoonsung Lee¹, Man S Kim¹

¹Translational-Transdisciplinary Research Center, Clinical Research Institute, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul 05278, Republic of Korea.

Antioxidants (Basel, Switzerland)

|August 28, 2025

Resumen

El sistema de transporte de carnitina regula la ferroposis, un proceso de muerte celular crucial para el tratamiento del cáncer. Dirigirse a este sistema, especialmente a la carnitina palmitoiltransferasa 1A (CPT1A), puede superar la resistencia a la ferroposis y mejorar las terapias contra el cáncer.

Área de la Ciencia:

La bioquímica
Biología celular
En el campo de la oncología

Sus antecedentes:

La ferroptosis, una muerte celular dependiente del hierro, es un objetivo terapéutico clave en el cáncer.
El sistema de transporte de carnitina es vital para el transporte de ácidos grasos y el metabolismo celular.

Objetivo del estudio:

Revisar la relación entre el transporte de carnitina y la ferroptosis en el cáncer.
Para explorar cómo los componentes de transporte de carnitina influyen en la sensibilidad a la ferroposis y la progresión del cáncer.

Principales métodos:

Revisión de la literatura sobre los componentes de la lanzadera de carnitina y la ferroptosis.
Análisis del impacto del transporte de carnitina en la homeostasis redox celular y el metabolismo de los ácidos grasos.
Examen de las interacciones con las proteínas relacionadas con la ferroposis.

Principales resultados:

Los componentes de la lanzadera de carnitina, incluida la carnitina palmitoiltransferasa 1A (CPT1A), tienen un impacto significativo en la ferroposis.
La orientación hacia CPT1A muestra potencial para superar la resistencia a la ferroposis en el cáncer.
El transporte de carnitina influye en la sensibilidad de las células cancerosas a los agentes que inducen la ferroposis.

Conclusiones:

El sistema de transporte de carnitina es un regulador crítico de la ferroposis en el cáncer.
Dirigirse al transporte de carnitina, particularmente CPT1A, ofrece estrategias terapéuticas para mejorar el tratamiento del cáncer y la eficacia de la inmunoterapia.
Se justifica una mayor investigación sobre la interconexión entre la lanzadera de carnitina, la ferroptosis y las vías de señalización del cáncer.

Palabras clave:

CPT1A el cáncer lanzadera de carnitina La ferroposis Peroxidación de los lípidos La homeostasis redox

Más Videos Relacionados

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

Author Spotlight: Detection of Mitophagy in Caenorhabditis elegans and Mammalian Cells Using Organelle-Specific Dyes

Author Spotlight: Detection of Mitophagy in Caenorhabditis elegans and Mammalian Cells Using Organelle-Specific Dyes

Published on: May 19, 2023

Videos de Conceptos Relacionados

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Necrosis

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

Translocation of Proteins into the Mitochondria

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...